e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Systemic effects of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dipeptidyl peptidase IV and aminopeptidase N activity in children with sleep apnea
M. D. Stankovic, V. Avramovic (Nis, Serbia And Montenegro)
Source:
Annual Congress 2005 - Systemic effects of OSA
Session:
Systemic effects of OSA
Session type:
Thematic Poster Session
Number:
2318
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. D. Stankovic, V. Avramovic (Nis, Serbia And Montenegro). Dipeptidyl peptidase IV and aminopeptidase N activity in children with sleep apnea. Eur Respir J 2005; 26: Suppl. 49, 2318
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Static lung volumes and spirometry measurements
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Target engagement confirmed in man with a dipeptidyl peptidase 1 inhibitor
Source: International Congress 2017 – Management of COPD
Year: 2017
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
Source: Eur Respir J 2001; 18: 1077
Year: 2001
Carbon anhydrase inhibitors for treatment of obstructive sleep apnoea
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Dipeptidyl peptidase I (DPPI) cleaves surfactant protein D (SP-D): A mechanism for immune compromise in the lung
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
Dipeptidyl peptidase-4 (DPP-4) may predict response to tralokinumab in patients with asthma
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
Source: Eur Respir J 2001; 17: 728-732
Year: 2001
Sleep disordered breathing in patients with glycogenosis type II
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015
Serum gamma-glutamyl transferase activity: A new prognostic factor in obstructive sleep apnea syndrome?
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
LATE-BREAKING ABSTRACT: Lack of association between circulating dipeptidyl peptidase-4 and type 2 biomarkers in asthma; data from U-BIOPRED and BIOAIR cohorts
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Physiological correlates to physical activity in obese patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013
Reduced hypoxic burden following carbonic anhydrase inhibition in obstructive sleep apnea – a randomized placebo-controlled study
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Adenotonsillectomy improves slow-wave activity in children with obstructive sleep apnoea
Source: Eur Respir J 2011; 37: 1144-1150
Year: 2011
Urinary biomarkers for obstructive sleep apnea syndrome: Lipocalin type prostaglandin-D synthase and F2-isoprostane
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
Short-term variability of biomakers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 459s
Year: 2004
The positive effect of CPAP therapy on the level of liver enzymes in obstructive sleep apnea patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Complex sleep apnoea syndrome
Source: Breathe 2013; 10: 372-380
Year: 2013
Obstructive sleep apnea prevalence in subjects with skeletal class II or class III with maxillary hypoplasia deformities waiting for orthognathic surgery.
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Renin and aldosterone levels in obstructive sleep apnea syndrome patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Association between ADAMTs proteinases and Obstructive Sleep Apnea
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017
Clinical status and activity of lysosomal carboxypeptidase A and cathepsin D in mixed saliva of cystic fibrosis patients
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept